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PRhythm Disorders in Heart Failure
Action Potential Dynamics Explain
Arrhythmic Vulnerability in Human Heart Failure
A Clinical and Modeling Study Implicating Abnormal Calcium Handling
Sanjiv M. Narayan, MD, FRCP, FACC,* Jason D. Bayer, MS,† Gautam Lalani, MD,*
Natalia A. Trayanova, PHD†
San Diego, California; and Baltimore, Maryland
Objectives The purpose of this study was to determine whether abnormalities of calcium cycling explain ventricular action
potential (AP) oscillations and cause electrocardiogram T-wave alternans (TWA).
Background Mechanisms explaining why heart failure patients are at risk for malignant ventricular arrhythmias (ventricular
tachycardia [VT]/ventricular fibrillation [VF]) are unclear. We studied whether oscillations in human ventricular
AP explain TWA and predict VT/VF, and used computer modeling to suggest potential cellular mechanisms.
Methods We studied 53 patients with left ventricular ejection fraction 28  8% and 18 control subjects. Monophasic APs
were recorded in the right ventricle (n  62) and/or left ventricle (n  9) at 109 beats/min.
Results Alternans of AP amplitude, computed spectrally, had higher magnitude in study patients than in controls
(p  0.03), particularly in AP phase II (p  0.02) rather than phase III (p  0.10). The AP duration and activa-
tion restitution (n  11 patients) were flat at 109 beats/min and did not explain TWA. In computer simulations,
only reduced sarcoplasmic reticulum calcium uptake explained our results, causing calcium oscillations, AP am-
plitude alternans, and TWA that were all abolished by calcium clamping. On prospective follow-up for 949 
553 days, 17 patients had VT/VF. The AP amplitude alternans predicted VT/VF (p  0.04), and was 78% concor-
dant with simultaneous TWA (p  0.003).
Conclusions Patients with systolic dysfunction show ventricular AP amplitude alternans that prospectively predicted VT/VF. Alter-
nans in AP amplitude, but not variations in AP duration or conduction, explained TWA at 109 beats/min. In com-
puter models, these findings were best explained by reduced sarcoplasmic reticulum calcium uptake. Thus, in heart
failure patients, in vivo AP alternans may reflect cellular calcium abnormalities and provide a mechanistic link with
VT/VF. (J Am Coll Cardiol 2008;52:1782–92) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.08.037f
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1udden cardiac arrest (SCA) from ventricular arrhythmias
ventricular tachycardia [VT]/ventricular fibrillation [VF])
laims 300,000 lives per year in the U.S. (1). Although
atients with systolic dysfunction are at high risk for SCA
1), few cellular or tissue-level mechanisms have been
dentified in humans to explain this arrhythmic propensity.
T-wave alternans (TWA) from the electrocardiogram
ECG) identifies patients with systolic dysfunction at risk
rom the *Department of Medicine and Whitaker Institute for Biomedical Engi-
eering, University of California, San Diego, California; and the †Department of
iomedical Engineering and Institute for Computational Medicine, Johns Hopkins
niversity, Baltimore, Maryland. This study was funded by the Doris Duke
haritable Foundation, the National Institutes of Health (HL83359 and HL70529),
nd the American Heart Association (0265120Y) to Dr. Narayan, and by the
ational Institutes of Health (HL063195, HL082729, and HL067322) to Dr.
rayanova. Dr. Narayan has received speaking honoraria from Cambridge Heart,
nc., St. Jude Medical, Boston Scientific, and Medtronic Corporation. Bruce
tambler, MD, served as Guest Editor for this article.r
Manuscript received June 16, 2008; revised manuscript received August 7, 2008,
ccepted August 14, 2008.or VT/VF (2). However, its mechanistic basis is unclear.
ntil recently, it was thought that TWA is caused by a steep
lope (1) of the action potential duration (APD) rate-
esponse curve (restitution) that, at very rapid rates (3), may
ead to APD alternans (4). In the presence of conduction
lowing or premature beats, APD alternans may develop an
pposite phase in adjacent myocardium (discordant alter-
ans), leading imminently to VT/VF (4). However, these
ast-rate mechanisms do not explain clinical TWA, which
redicts outcome only if present at slow rates (109
eats/min) and is most predictive at 90 beats/min (2,5).
oreover, spontaneous clinical VT/VF often initiates in the
etting of nonelevated heart rates (6). Clinical (7) and
heoretical (8) data show that human APD does not
uctuate at such slow rates.
Animal studies show that fluctuations in cytosolic cal-
ium may also cause APD alternans and arrhythmias (4,9–
1). Although such alternans occurs at fast rates, most
eports have not studied failing hearts with calcium overload
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November 25, 2008:1782–92 Action Potential Alternans in Heart Failure12), in which calcium oscillations may hypothetically occur
t slower rates. Theoretically, TWA may also result from
scillations in myocyte activation time (AT) (i.e., conduc-
ion) (4,13) or sodium channel inactivation (14,15).
We hypothesized that, in patients with systolic heart
ailure, abnormal calcium handling causes oscillations of
ytosolic calcium at modest heart rate elevation, leading
o fluctuations in AP amplitude that link TWA with
T/VF. We tested this hypothesis using ventricular
onophasic APs in patients with systolic dysfunction,
ogether with computational modeling to study whether
P amplitude alternans is best explained by abnormali-
ies in cellular calcium, sodium, or conduction, and prospec-
ive follow-up to determine whether AP amplitude alter-
ans predicts spontaneous VT/VF.
ethods
atient recruitment. This study was approved by the joint
nstitutional Review Board of the Veterans Affairs and Uni-
ersity of California Medical Centers, San Diego, and patients
rovided written informed consent. We recruited 53 study
atients with left ventricular ejection fraction (LVEF) 40%
ndergoing programmed ventricular stimulation and 18
ontrol patients (LVEF 40%) undergoing ablation of
aroxysmal supraventricular tachycardias. We excluded pa-
ients with sustained VT/VF or SCA, within 30 days of
n acute coronary syndrome or 6 weeks of coronary
evascularization, and those with permanent pacemakers.
acing at electrophysiologic study. Patients were studied
n the post-absorptive state. A 7-F monophasic action
otential (MAP) catheter (EP Technologies, Sunnyvale,
alifornia) was advanced transvenously to the apex of the
ight ventricle (RV) (n  62), or retrogradely across the
ortic valve to the left ventricle (LV) (n  6 study patients
nd n  3 control subjects). MAPs were recorded simulta-
eously at 2 sites in 11 of these patients. After digitization
t 1 kHz from our recorder (Bard, Billerica, Massachusetts),
lectrograms were analyzed at 0.05 to 500 Hz (MAPs), 30
o 500 Hz (most intracardiacs), and 0.05 to 100 Hz (ECG).
Research was performed before programmed stimulation
study patients) or ablation (control patients) in the popu-
ation for whom we recently reported that APD restitution
id not predict VT/VF (7). First, we studied MAPs and
imultaneous TWA during right atrial pacing at 109 beats/
in for 90 s (16) (Figs. 1 and 2). Second, in patients with
ual-site MAPs, we measured AT to the second catheter
fter RV apical pacing, using 10 drive train beats at cycle
ength 500 ms then single extrastimuli coupled at 400 ms, in
0-ms steps to 300 ms, and then in 10-ms steps to
efractoriness. The clinical procedure was then performed,
nd implantable cardioverter-defibrillators were implanted
ccording to clinical guidelines.
nalysis of AP alternans. Electrograms were exported at
6-bit digital resolution for offline analysis using custom uoftware written (by S.M.N.) in
abview (National Instruments,
ustin, Texas).
The AP alternans was computed
pectrally as performed for TWA.
sing validated software (17), 64
ontiguous APs were selected20
eats after the onset of pacing,
aseline corrected to a 10-ms seg-
ent starting 20 ms before AP
nset, and aligned to phases 0 to I.
uccessive APs were represented
s 2-dimensional matrices R (n, t),
here n indicates beat number (0
n  63) and t the time sample.
fast-Fourier transform was used
o compute power spectra across
eats (arrows in Fig. 1) for each t,
hen spectra were summated
cross the AP (Figs. 1, 2, and 3).
The AP amplitude was de-
ned for phase II or III as the
eight above baseline. The mag-
itude of AP amplitude alternans
as represented by the dimen-
ionless k-score:
k-score
Tnoise
noise
here T is spectral magnitude
t 0.5 cycles/beat, and noise and
noise are the mean and SD of
oise. Thus, k-score scales with
he SD of noise. The noise win-
ow (0.33 to 0.49 Hz) was se-
ected adjacent to alternans fre-
uency (avoiding the 0.125 to
.25 Hz respiratory peak), as
ith TWA. A k 0 indicates
hat alternans exceeds noise (5).
P amplitude was also measured
s the absolute voltage of alter-
ation, Valt (in V), that is, not
caled by noise SD, as:
ValtTnoiseAP duration
e studied AP amplitude for the entire AP, in other words,
rom the end of the alignment window (phases 0 to I) to the
ime of APD at 90% repolarization (APD90), and for phase
I (defined as the first half of this interval) and phase III
second half). We did not study phase I alternans because
Abbreviations
and Acronyms
AP  action potential
APD  action potential
duration
APD90  action potential
duration at 90%
repolarization
AT  activation time
[Ca]i  intracellular
calcium
CaSR  sarcoplasmic
reticulum calcium
DI  diastolic interval
ECG  electrocardiogram
ICaL  L-type calcium
current
Irel  sarcoplasmic
reticulum calcium release
current
Ito  transient outward
current
Iup  sarcoplasmic
reticulum calcium uptake
current
LV  left
ventricle/ventricular
LVEF  left ventricular
ejection fraction
MAP  monophasic action
potential
ROC  receiver-operator
characteristic
RV  right
ventricle/ventricular
SCA  sudden cardiac
arrest
h,j  time constants of
fast and slow sodium
channel gating
TTP  Ten
Tusscher-Panfilov
TWA  T-wave alternans
Valt  absolute voltage of
alternation
VF  ventricular fibrillation
VT  ventricular
tachycardiapstroke velocity is slower in MAPs than in single cell APs
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Action Potential Alternans in Heart Failure November 25, 2008:1782–92nd potentially unreliable (18), and because aligning beats to
hases 0 to I minimizes phase I alternans.
lternans of APD. APD90 was measured for these 64
eats with validated software (7). After identifying phase II
maximum plateau) and phase IV (diastolic) voltages,
PD90 spanned the interval from phase 0 maximum slope
dV/dt) to 90% voltage recovery. Diastolic interval (DI)
panned the interval from APD90 of the prior beat to AP
nset of the current beat. APD90 alternans was defined if
ariations in 5 beats had opposite sign (19).
easurement of TWA alternans. We analyzed ECG
WA using HearT-wave (Cambridge Heart, Bedford,
assachusetts) simultaneously with AP measurements.
ach TWA report was classified by consensus from 3
linded reviewers as positive, negative, and indeterminate
5). We compared positive and negative TWA against
lternans of AP amplitude alternans and APD alternans.
or outcome analyses, we grouped positive and indetermi-
ate tests as “abnormal” TWA (2).
nalysis of activation restitution. In 11 patients, we
Figure 1 Ventricular AP Alternans
This 59-year-old man had ischemic cardiomyopathy and left ventricular ejection fra
shows minimal oscillations over time. However, when 64 consecutive beats were
the separation of even (blue line) and odd (red line) beats. (D) AP amplitude alte
this spectrum across beats, as peak magnitude at 0.5 cycles/beat. (E) T-wave alt
leads, with low levels of bad beats and noise, and no confounding respiratory (Res
monophasic action potential; RV  right ventricle.easured AT from the RV apex to the second MAP site cLV, n  9; RV outflow tract, n  2) after progressively
arly extrastimuli (Fig. 4). The AT is the difference in AP
nset between sites. We used pairs (DI, AT) to plot AT
estitution (20) as best-fit straight lines for flat AT restitu-
ion (arbitrarily, absolute slope 0.2), and for lengthening
T (conduction slowing) at short DI. We report DI where
T begins to lengthen (4).
omputational modeling. To study mechanisms explain-
ng AP and TWA, a human LV transmural wedge prepa-
ation was developed with dimensions shown in Figure 5A.
embrane kinetics were represented by the Ten Tusscher–
anfilov (TTP) model of human ventricular tissue (14).
ransmural heterogeneity in ion channel expression be-
ween the 3 cell layers was modeled according to Table 1 of
eiss et al. (21). Intracellular and extracellular components
ere coupled in 3 dimensions using a bidomain formulation
nd assigned conductivity values to produce transmural
onduction velocities of 0.4 m/s in endocardial and mid-
yocardial (M-cell) layers, and 0.28 m/s in epicardium (22).
As in the clinical protocol, the endocardium was paced at
LVEF) of 20%. (A) Pacing at 109 beats/min; (B) action potential duration (APD)
posed, (C) action potential (AP) amplitude shows marked alternans, shown by
(k-score  10.4, absolute voltage of alternation [Valt]  175 V) is depicted on
(TWA) is positive at this time (gray areas) in X, Y, and vector magnitude (Vm)
art rate (HR), or RR-interval alternans. FFT  fast-Fourier transform; MAP ction (
superim
rnans
ernans
p), heycle length of 550 ms for 84 beats. Three sets of simula-
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November 25, 2008:1782–92 Action Potential Alternans in Heart Failureions were performed: 1) control; 2) Iup, the sarcoplasmic
eticulum calcium uptake current, scaled by 25% to 200%;
nd 3) h,j, the time constants of fast and slow sodium
hannel inactivation, scaled by 25% to 200%. These param-
ters were selected because 33% to 60% down-regulation of
up protein has been reported in failing human myocytes
Table 2 of Hasenfuss et al. [23]) and abnormal sodium
nactivation may potentiate alternans (14,15). We modified
up or h,j simultaneously in all 3 cell layers of the LV wedge
reparation before pacing.
Pseudo-ECGs were computed at a centrally located point
cm from the epicardium (24). Microvolt TWA was
ssigned if the voltage difference between successive T
aves alternated in sign and exceeded 1/500 of normal
-wave amplitude (25). Spectral analysis was used to
uantify TWA and AP amplitude alternans (17), with AP
easurements taken at the center of the endocardial, mid-
yocardium, and epicardial regions in the model.
rospective follow-up. LV dysfunction patients were fol-
owed up prospectively for 949  553 days using 6-monthly
evice interrogations, electronic medical records, and tele-
hone questionnaires until the first event or July 27, 2007.
o patient was lost to follow-up. Arrhythmia detection was
rogrammed uniformly in implantable cardioverter-
efibrillator recipients (n  45), and events were verified by
Figure 2 Alternans Predominates in AP Phase II of LV APs
Alternans predominates in AP phase II of left ventricular (LV) APs in this 59-year-ol
tion (APD) does not oscillate during pacing. However, (C) marked AP amplitude alt
(arrows, k-score  7.9, absolute voltage of alternation [Valt]  59 V) but is unde
(E) T-wave alternans (TWA) was positive at this time (arrows) in leads Y, Z, and Vonsensus. The primary end point was appropriate device aherapy or sustained VT/VF. The secondary end point was
he combined occurrence of ventricular arrhythmias or
ll-cause mortality.
tatistical analysis and sample size considerations. Con-
inuous data are presented as mean  SD, and were
ompared between study and control subjects using the
-tailed t test. Paired variables were compared using the
aired, 2-tailed t test. The Fisher exact test was applied to
ontingency tables. Statistics were analyzed using SPSS
oftware (SPSS Inc., Chicago, Illinois). Significance was
ssessed at a 2-tailed alpha level of 0.05.
For the prospective study, we split the study population
nto a training set (first, n  26) and a validation set (last,
 27), based on alphabetical ordering (no patients were
elated). Receiver-operator characteristic (ROC) analysis on
he training set was used to define optimum cutpoints that
ere used to construct Kaplan-Meier survival curves for the
alidation set.
esults
aseline characteristics are listed in Table 1.
linical ventricular AP alternans. Figure 1A shows RV
Ps in a study patient who had positive TWA. Figure 1C
hows 64 consecutive superimposed beats, successively col-
red red, blue, red, and so on. Baseline correction and
with coronary artery disease and an LVEF of 21%. (A, B) Action potential dura-
in phase II is seen (red/blue separation). (D) AP alternans occurs in phase II
le in phase III (k-score  0.38); AP duration variations were also minimal.
reviations as in Figure 1.d man
ernans
tectab
m. Abblignment was effective, yet phases II and III segregate into
e
a
s
b
i
k
t
A
u
a
2
m
c
(

y
w
A
p
c
(
i
A
p
m
R
k
R
o
t
d
A
s
t
m
0
a
t
v
I
(
n
a
A
c
1786 Narayan et al. JACC Vol. 52, No. 22, 2008
Action Potential Alternans in Heart Failure November 25, 2008:1782–92ven (blue) and odd (red) groups; in other words, AP
mplitudes alternate. At each time point (arrows; only 3
hown for clarity), a fast-Fourier transform across all 64
eats resulted in the spectrum (Fig. 1D) in which alternans
s the magnitude at 0.5 cycles/beat (every other beat). Here,
-score  10.4. Figure 1B shows small magnitude oscilla-
ions in APD90 (3  1 ms) in this patient.
lternans of amplitude is not uniform within APs. Fig-
re 2 illustrates nonuniform alternans within the LV AP in
study patient. Across the entire AP, alternans k-score 
.23. However, oscillation between even/odd beats was
ore evident in phase II than in phase III (Fig. 2C). On
omparison, amplitude alternans was present in phase II
k-score  7.89) yet was undetectable in phase III (k-score
0.38) (Fig. 2D). The APD90 did not oscillate (Fig. 2B),
et simultaneous TWA was positive (Fig. 2E).
Figure 3A shows no RV AP alternans in a control patient
ith negative TWA. Figure 3B shows another example of
P amplitude alternans in phase II in a study patient with
ositive TWA.
Overall, AP amplitude alternans k-score was nonsignifi-
antly higher in phase II than in phase III in study patients
3.7  4.4 vs. 2.1  3.7, p  0.057 paired t test), but not
Figure 3 AP Amplitude Analyses
(A) No AP amplitude alternans in a 66-year-old male control patient with LVEF of 6
(arrow) (k-score  6.3; absolute voltage of alternation [Valt]  72 V) in a 72-yea
superimposed odd/even beats. Abbreviations as in Figure 1.n control subjects (0.4  0.8 vs. 0.2  1.0, p  0.47). tP amplitude alternans between ventricular sites. In
atients with dual-site recordings (n  11; 6 with cardio-
yopathy), AP amplitude alternans was similar between
V apex, RV outflow tract, and LV apex. Alternans
-scores for the entire AP were similar for RV apex versus
V outflow tract (1.71  2.30 vs. 1.93  3.39, p  0.76)
r LV (0.36  1.44 vs. 0.11  0.39, p  0.79). We
herefore pooled single-RV and -LV site data. In patients with
ual-site recordings, we used data from the RV apex.
P amplitude alternans separated study from control
ubjects. The AP amplitude alternans was more prevalent,
hat is, k-score 0 (72% vs. 33%, p  0.04), with higher
agnitude (k-scores  3.26  4.20 vs. 0.31  0.95, p 
.03) in study patients than in control patients. The AP
mplitude alternans had higher magnitude in the study group
han in the control group in phase II (k-score  3.66  4.48
s. 0.44  0.77, p  0.02) and, nonsignificantly, in phase
II (k-score  2.13  3.69 vs. 0.25  0.96, p  0.10)
Table 2). Results were similar for Valt, although they may
ot have reached significance because Valt may be elevated
rtifactually if the noise SD is high (Table 2).
T (conduction) restitution. For patients with ischemic
ardiomyopathy, Figure 4A shows preserved activation res-
sting negative for TWA. AP alternans k-score  1.1. (B) AP phase II alternans
an with ischemic cardiomyopathy and LVEF of 26%. Red/blue lines indicate6% te
r-old mitution, namely, AT prolongs only for short DI 40 ms
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November 25, 2008:1782–92 Action Potential Alternans in Heart Failureslope 0.66), whereas Figure 4B shows broad activation
estitution; in other words, AT prolonged for DI up to 120
s (slope 0.37). The DI range for which conduction
lowed was 120 ms in study subjects and 60 ms in
ontrol subjects (Table 2).
Thus, AT did not prolong for DI corresponding to 109
eats/min where TWA is measured (DI  270 to 290 ms)
Figs. 1, 2, and 3), so that conduction dynamics are unlikely
o explain TWA.
PD alternans. APD alternans was presented intermit-
ently for more beats in study patients (16  13 beats) than
n control patients (4  5 beats, p  0.015). Neither the
umber of alternating beats nor the very small APD
lternans amplitude (Table 2) separated groups. The num-
er of beats showing APD alternans poorly predicted the
rimary end point (area under ROC curve: 0.45).
elationship of TWA to intracardiac measures. TWA
as positive in 33 patients. Concordance between TWA
nd AP amplitude alternans (positive if k-score 1.47) was
8% (kappa  0.48, p  0.002). The absolute values of AP
mplitude alternans and simultaneous TWA (averaged
cross repolarization) varied linearly, and AP amplitude
lternans was 1 to 2 orders of magnitude larger than TWA
Figure 4 Conduction Does Not Vary at 109 Beats/Min
Conduction does not vary (“flat restitution”) at 109 beats/min (i.e., diastolic interv
(RVA) extrastimuli to a second monophasic action potential (MAP) site. This was t
a 55-year-old man with LVEF of 35%; and (B) broad restitution, whereas AT prolon
nary artery disease. CL  cycle length; RVOT  right ventricular outflow tract; otheAP amplitude alternans magnitude  38.5  TWA sagnitude 26.5; p 0.03), as in animal studies (26). The
agnitude of AP amplitude alternans agreed with studies of
uman unipolar electrograms (27). TWA correlated poorly
ith APD alternans (p  0.60).
echanisms for AP amplitude alternans. INSIGHTS FROM
OMPUTATIONAL MODELING. The AP amplitude and
WA arose simultaneously when Iup was reduced beyond
he threshold 70% (Fig. 5B), and resembled clinical AP
lternans (compare Fig. 5D and Figs. 1, 2, and 3B). Indeed,
up reduction 74% caused sustained alternans in intracel-
ular calcium, AP amplitude, and TWA (Fig. 5B). At 74%
up reduction, modeled k-scores, Valt, and intermittent
PD90 alternans (Figs. 5B and 5D, Table 3) agreed with
linical observation (Table 2).
To further define the mechanism for AP amplitude
lternans in phases II and III, we scaled sarcoplasmic
eticulum release current, Irel, and L-type calcium current,
CaL, from 25% to 200%. The ICaL reduction 48%
roduced alternans in AP amplitude and intracellular cal-
ium (data not shown). However, on clamping ICaL, [Ca]i,
r sarcoplasmic reticulum calcium (CaSR) in a single
ndocardial cell with reduced Iup (Fig. 6A), only clamping
aSR completely abolished AP alternans (Fig. 6B). As
 270 to 290 ms), measured as activation time (AT) from right ventricle apical
(A) preserved restitution, where AT prolonged only for very short DI (40 ms) in
r DI 120 ms in a 62-year-old man with LVEF of 31%. Both patients had coro-
eviations as in Figure 1.al [DI]
rue for
ged fo
r abbruggested by the modeling study of Livshitz and Rudy (10),
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Action Potential Alternans in Heart Failure November 25, 2008:1782–92e found that clamping [Ca]i abolished alternans in APD,
ut not in diadic subspace calcium and CaSR. Therefore,
lternans in AP phase I and II amplitude persisted under
his constraint by fluctuations in the calcium-dependent
nactivation component of ICaL.
AP amplitude alternans (and TWA) did not occur in any
ayer of control LV wedge, nor in cardiomyopathy with
ncreased or decreased sodium inactivation (data not
hown). Because APs in Figure 5B suggest phase I alter-
ans, we studied whether altering transient outward current,
to, magnitude, and time constants for voltage-dependent
nactivation and activation by 25% to 200% could cause
P alternans. We were unable to demonstrate this (data
ot shown).
Finally, transmural conduction velocity did not vary by
0.1 m/s in any LV wedge layer, and beat-to-beat varia-
ions were not observed at 109 beats/min with any modeled
Figure 5 Modeled Reduction in Calcium Uptake
Modeled reduction in calcium uptake 70% (but not altered transient outward cur
(A) Human left ventricle (LV) wedge dimensions (endocardium  orange; mid-myo
develop in the endocardium as sarcoplasmic reticulum calcium uptake current [Iup
tude (middle left panel) and peak diastolic intracellular calcium ([Ca]i) (far right p
els). The number of alternating beats out of 64 is indicated. (D, top) Control endo
lines, depicting AP phase II and T-wave data ranges. (D, bottom) AP phase II and
lines  control. Note similarity to clinical alternans (Figs. 1, 2, and 3B). T-wave loc
as in Figure 1.onic changes. eP indexes and outcome. We assessed outcome in LV
ysfunction patients, of whom 17 experienced the primary
nd point and 15 died. AP amplitude alternans predicted
utcome when applied to the entire AP or phase II; we
eport the former because clinical surrogates (unipolar
lectrograms) exist for the entire MAP (27,28).
Patients reaching the primary end point had greater AP
mplitude alternans than did those who did not (k-score 
.4  4.1 vs. 1.8  3.6, p  0.02). Patients reaching the
econdary end point also had greater AP amplitude alter-
ans than those who did not (k-score  4.4  4.9 vs. 1.6 
.7, p  0.06).
From ROC analysis of the training set (n  26), AP
mplitude alternans k-score 1.47 best predicted the pri-
ary end point and was defined as “positive” (area under
urve: 0.85). Confirming its validity, a nearly identical
utpoint (1.48) was obtained by ROC analysis of the
o] or sodium channel inactivation) causes AP and TWA at 109 beats/min.
 light green; epicardium  light blue). (B) Spectral AP alternans and TWA
es to 0.25 to 0.30 of baseline. (C) Mean change in endocardial phase II ampli-
omputed at locations indicated by gray circles (far left and middle right pan-
l AP and pseudo-electrocardiogram with bounding boxes, denoted by dashed
alternans for Iup reduced by 74%; red lines  odd; blue lines  even; orange
used to compute TWA amplitude differences are denoted by *. Abbreviationsrent [It
cardium
] reduc
anel) c
cardia
T-wave
ationsntire LV dysfunction population (area under curve: 0.86).
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November 25, 2008:1782–92 Action Potential Alternans in Heart Failuresing k-score 1.47, AP amplitude alternans was 91%
oncordant between sites in patients with dual-site record-
ngs (kappa  0.79). ROC analysis of the training set for
P amplitude alternans in phase II yielded a similar
utpoint (k-score 1.51; area under curve: 0.88).
On Kaplan-Meier analysis of validation patients (n  27;
arrhythmic events, 9 deaths) (Fig. 7), AP amplitude
lternans k-score 1.47 separated patients with from those
ithout the primary end point with 100% sensitivity, 37%
pecificity, 100% negative predictive value, and 40% positive
redictive value (p  0.04). The primary end point was also
redicted by positive (p  0.03) and abnormal (p  0.02)
WA in all study patients. APD alternans at 109 beats/min
id not predict the primary end point (p  0.53).
iscussion
n patients with systolic heart failure, alternans of RV or LV
P amplitudes developed at modest heart rate elevations
nd predicted malignant arrhythmias on long-term follow-
p. Notably, while AP amplitude alternans (particularly in
hase II) explained TWA, we found that APD and intra-
entricular conduction did not oscillate at slow heart rates.
n computational models, reduced Iup to levels reported in
ailing myocytes produced alternans that agreed with our
linical data, and resulted from calcium oscillations. More-
ver, clamping sarcoplasmic calcium abolished AP ampli-
ude and T-wave oscillations. These results link malignant
uman ventricular arrhythmias with abnormal calcium cy-
aseline Clinical Characteristics
Table 1 Baseline Clinical Characteristics
LV Dysfunction
(n  53)
Preserved LV
(n  18) p Value
Age, yrs 65.4 13.3 65.8 10.6 0.91
Sex, male/female 52/1 15/3 0.02
Ejection fraction, % 28 8 58 12 0.001
Coronary disease, n 47 4 0.001
Hypertension, n 11 3 0.71
Diabetes mellitus, n 8 2 0.67
Serum Na	, mmol/l 136 17 139 2 0.14
Serum K	, mmol/l 4.4 0.5 4.2 0.4 0.12
Serum Ca2	, mg/dl 9.0 0.5 9.0 0.5 0.90
Serum Mg2	, mmol/l 2.1 0.2 2.0 0.2 0.30
Serum HCO3
, mmol/l 26 4 27 3 0.57
Plasma BNP, pg/ml 640 825 131 282 0.02
Medication use, %
Beta-blockers 39 7 0.01
ACE inhibitor/ARB 47 11 0.01
Spironolactone 10 1 0.18
CCB 11 4 0.89
Digoxin 21 2 0.03
Amiodarone 5 1 0.61
Statins* 38 9 0.09
he p value is for comparisons between study and control groups. *3-hydroxy-3-methylglutaryl
oenzyme A reductase inhibitors.
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; BNP  B-type
atriuretic peptide; CCB  calcium-channel blocker; LV  left ventricle.ling, and suggest the novel clinical use of AP amplitude
9
alternans to indicate calcium overload and arrhythmic risk
n heart failure patients.
otential mechanisms for AP alternans. AP amplitude
lternans was more prevalent in heart failure patients than in
ontrol patients and in those with subsequent VT/VF than
n those without. This finding was particularly true in AP
hase II compared with phase III. These findings agree with
ata that human ventricular APD does not alternate at slow
ates (7,8), and confirm human unipolar electrogram alter-
ans reported by Selvaraj et al. (27), with differences likely
xplained by the wider spatial integration of unipolar
lectrograms and the largely epicardial alternans reported by
elvaraj et al. (27).
Computational modeling showed that reduced Iup, to
evels observed in failing myocytes (29), explained AP
mplitude and TWA and linked them to cytosolic calcium
scillations. Although somewhat counterintuitive, calcium
scillations may alter AP amplitude but not APD because
arying constituents of calcium homeostasis have opposing
ffects on APD. Positive calcium-voltage (Ca-Vm) coupling
where calcium transients prolong APD) may be opposed by
egative Ca-Vm coupling (from operation of the sodium-
alcium exchanger in reverse mode, sarcoplasmic reticulum
alcium release inactivation of ICaL, or intracellular calcium-
elated enhancement of the slow component of the delayed
ectifier current) (11,30). In addition, our results may be
nfluenced by defining phase III as the second half of the AP
hat may include the late AP plateau. Conversely, oscilla-
ions of APD arise at rapid rates (9,11) and reflect decreased
epolarization andonduction Dynamics: Clinical Data
Table 2 Repolarization andConduction Dynamics: Clinical Data
LV Dysfunction Preserved LV p Value
TWA 0.01
Positive 19 1
Indeterminate 14 3
Negative 20 14
AP amplitude alternans
Entire AP, k-score 3.26 4.19 0.31 0.95 0.03
Valt, V 49 116 11 4 0.65
Phase II, k-score 3.66 4.48 0.44 0.77 0.02
Valt, V 93 203 2.0 4.0 0.25
Phase III, k-score 2.13 3.69 0.25 0.96 0.10
Valt, V 27 57 2.0 3.4 0.26
APD90 during pacing for TWA
APD90, ms 272 43 258 43 0.33
Diastolic interval, ms 278 43 293 43 0.33
APD alternans, no. of beats 16 13 4 5 0.02
Mean  SD (range, median) (0–58, 14) (0–12, 2.5)
Beat-to-beat magnitude, ms 8 14 3 4 0.28
Activation restitution
DI below which AT prolonged 54.0 41.0 35.0 35.4 0.59
Mean  SD (range) (20–120) (10–60)
Restitution slope (slowing phase) 1.32 1.18 0.82 0.17 0.59
ontinuous data are presented as mean  SD.
AP  action potential; APD  action potential duration; APD90  action potential duration at
0% repolarization; AT  activation time; DI  diastolic interval; TWA  T-wave alternans; Valt 
bsolute voltage of alternation.
RC
ECG  electrocardiogram; Iup  sarcoplasmic reticulum calcium uptake current; other abbrevi-
ations as in Table 2.
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Action Potential Alternans in Heart Failure November 25, 2008:1782–92Figure 6 Sarcoplasmic Reticulum Calcium Clamping Abolishes Alternans in Modeled Endocardial Cells
(A) Odd (solid lines) and even (dotted lines) beats for a single endocardial cell at steady state with sarcoplasmic reticulum calcium uptake current (Iup) reduced by
70%, showing alternans in action potential (AP), intracellular calcium ([Ca]i), L-type calcium current (ICaL), and sarcoplasmic reticulum calcium (CaSR). (B) APs superim-
posed (blue line  odd; red line  even) for (left) ICaL, (middle) [Ca]i, and (right) CaSR, clamped to the odd traces in (A). Clamping to even beats did not change the
results.Figure 7 Kaplan-Meier Survival Curve
Based Upon AP Amplitude Alternans
Action potential (AP) amplitude alternans (k 1.47) prospectively predicted
sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) or implantable
cardioverter-defibrillator (ICD) therapy (in the validation sample) on Kaplan-
Meier analysis (p  0.04). Solid line  AP amplitude alternans; dashed line 
no AP amplitude alternans.epolarization Dynamics: Simulation Data
Table 3 Repolarization Dynamics: Simulation Data
Modeled HF
(Iup0.26) Control
AP amplitude alternans
Entire AP, k-score 12.66 0.03
Valt, V 198.1 9.30
Phase II, k-score 5.24 0.01
Valt, V 127.44 5.85
Phase III, k-score 7.41 0.02
Valt, V 151.64 7.22
Computed ECG TWA
k-score 1.20 0.01
Valt, V 1.97 0.15
Presence of microvolt TWA 	 
APD90 during pacing for TWA
APD90, ms 325 2 334 1
Diastolic interval, ms 225 2 216 1
Beat-to-beat 
APD90, ms 1.0 0 1.0 0
APD alternans, no. of beats 13 0
Intracellular calcium, M
Diastolic [Ca2	]I 0.22 0.00 0.14 0.00
Peak [Ca2	]i 0.50 0.05 1.44 0.03
Peak diastolic [Ca2	]i 0.28 0.05 1.30 0.03
ontinuous data are presented as mean  SD.
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November 25, 2008:1782–92 Action Potential Alternans in Heart Failureapid component of the delayed rectifier current and
odium-calcium exchanger activity (10).
The absence of alternans with increased sodium inactivation
s consistent with Tusscher et al. (14). Unlike that study, we
id not observe alternans with decreased sodium channel
nactivation since APD and activation restitution were flat at
he pacing cycle length of 550 ms. Indeed, even in patients
ith infarct scar and broad activation restitution (Fig. 4B), and
omputationally, AT prolongation required shorter DI (i.e.,
ates faster than109 beats/min). We acknowledge, however,
hat higher spatial resolution mapping is needed to definitively
ddress regional conduction slowing.
elationship between AP and TWA. These data show
hat AP amplitude alternans predicts spontaneous VT/VF,
nd extend the elegant studies of Selvaraj et al. (27) and
hristini et al. (31) linking intracardiac alternans with
WA. Our results also suggest that intracardiac alternans
rom implanted devices (32) may indicate calcium overload
nd electrical instability in heart failure patients.
Concordance between AP amplitude and TWA agrees
ith prior reports (31), suggesting shared mechanisms.
evertheless, TWA also likely reflects spatial nonuniformi-
ies in repolarization, as noted by alternans of the activation-
ecovery interval (27) and colocalization of TWA near scar
33). Modeling showed that AP amplitude alternans was
ost marked in endocardial cells, which are characterized by
smaller maximum Ito conductance than other cells (0.073
s. 0.294 nanosiemens per picofarads) (14), and may explain
hase II alternans. However, Selvaraj et al. (27) found
nipolar LV alternans in the epicardium; detailed intraop-
rative mapping may help to resolve these inconsistencies.
agnitude relationship of AP and TWA. AP amplitude
lternans was 2 orders of magnitude larger than TWA, as in
nimals (26). Selvaraj et al. (27) observed similar magnitude
lternans in human unipolar activation-recovery intervals
40 to 70 V peak differences in Figs. 1 and 2 of Selvaraj
t al. [27]).
tudy limitations. First, clinically, although this is the
argest reported series of patients with ventricular MAPs to
ate, the population is small for outcome analysis, which
educes the precision of Kaplan-Meier estimates (computed
or the entire study duration). Second, our results are limited
y spatial resolution. Although that likely does not detract
rom our findings, additional sampling may refine analyses
f regional repolarization and conduction dynamics. Third,
lthough AP amplitude alternans k-scores differed signifi-
antly between groups, differences in Valt were not signifi-
antly different. This finding is explained by the large Valt
ange in study patients (Table 2) that likely reflects artifac-
ual exaggeration of Valt when noise SD is high, whereas
-scores are scaled to noise. Fourth, cardiac motion, respi-
atory artifact, or baseline wander could theoretically influ-
nce our analyses. However, our APs had consistent shape
n raw superimposed tracings (Figs. 1, 2, and 3), whereas
rtifacts should not alternate, alternans showed high signal-
o-noise ratio (optimal k-score  1.5 vs. k-score 3 in Sxercise TWA) (5), and artifact would not track outcome.
ifth, cellular mechanisms could be influenced by medica-
ions and blood chemistry, yet these factors were similar
etween groups (Table 1). Sixth, our sample is also predom-
nantly male.
A limitation of our modeling is the lack of realistic
eometry and fiber anisotropy, which alters repolarization
nd the pseudo-ECG. However, that should not impact our
ndings that link cellular calcium with repolarization oscil-
ations (shown in single cells as well). Moreover, Iup is
ependent on various factors including sarcoplasmic reticu-
um Ca2	-adenosine triphosphatase, phospholamban, cal-
odulin, and calcium/calmodulin-dependent protein kinase
I, yet in the TTP model, Iup is a functional representation
f all of these factors. In vitro studies typically report
arcoplasmic reticulum Ca2	-adenosine triphosphatase pro-
ein levels, yet tissue inhibitors (e.g., dephosphorylated
hospholamban) may translate reported 33% to 60% protein
eductions (23) into greater functional reductions in Iup. We
re, therefore, comfortable that modeled Iup reductions
70%) are pathophysiologically plausible. Last, modeled
hase III Valt was larger than observed clinically. Neverthe-
ess, modeling agreed with the observation that AP ampli-
ude alternans was less prevalent in phase III than phase II,
nd that APD alternans was intermittent and only a few
illiseconds in magnitude. The discrepancy may reflect a
teeper descent of AP phase III in the TTP model (Figs. 5
nd 6) than in clinical MAPs (Figs. 1 to 4), enabling
ubstantial changes in phase III amplitude with less effect on
PD. The TTP model may ineffectively represent the
ensitivity of repolarizing potassium currents to intracellular
alcium alterations in heart failure (11) that cause negative
a-Vm coupling and the more gradual phase III descent
een clinically. For these reasons, we believe that these phase
I/III differences do not detract from the similarity between
odeled and clinical AP alternans (e.g., Fig. 5D vs. Figs. 1,
, and 3B), and our mechanistic conclusions.
onclusions
n patients with systolic heart failure, in vivo alternans of
V and LV AP amplitudes at modest heart rate elevations
redicted VT/VF and explained TWA. Computational
odels showed that reduced CaSR uptake resulted in
alcium oscillations that explained electrophysiologic alter-
ans, and were eliminated by calcium clamping. These data
uggest that AP amplitude alternans in heart failure patients
s linked to malignant arrhythmias via abnormal calcium
andling, and provides a novel clinical index of calcium
verload and arrhythmic risk.
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